跳至主要内容
临床试验/ISRCTN13970288
ISRCTN13970288进行中(未招募)Unknown

A randomised, placebo-controlled experimental study of dimethyltryptamine on alcohol reward memory in non-treatment-seeking excessive drinking: effects on drinking, therapeutic mechanisms and neural biomarkers

niversity College London0 个研究点目标入组 120 人开始时间: 2024年8月1日最近更新:
适应症

试验速览

阶段
Unknown
状态
进行中(未招募)
发起方
入组人数
120

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Aged 21 - 65 years
  • 2. Normal or corrected-to-normal vision and hearing
  • 3. Fluent English
  • 4. Scoring >10 on the AUDIT questionnaire
  • 5. Drinking =3 times a week
  • 6. Drinking >20 UK units (160g etOH) per week for women or >35 UK units (280g etOH) per week for men; equivalent to = WHO ’moderate risk’ criteria
  • 7. Motivated to reduce consumption based on the Motivation to Reduce Alcohol Consumption (MRAC) Scale

排除标准

  • 1. Currently seeking or receiving treatment for alcohol use disorder (AUD) or other substance use disorders (SUDs)
  • 2. Any current major mental health, neurological or physical health disorder
  • 3. BMI <18 or >35 kg/m²
  • 4. Severe alcohol dependence as assessed by Severity of Alcohol Dependence Questionnaire (SADQ)
  • 5. Personal or family history of psychosis or schizophrenia
  • 6. Personality disorder (assessed by Structured Assessment of Personality Abbreviated Scale [SAPAS] and clinical psychologist screening)
  • 7. Lifetime trauma exposure (assessed by Stressful Life Events Screening Questionnaire [SLESQ])
  • 8. >3 lifetime uses of DMT
  • 9. Use of psychedelics within the past 6 months / any regular lifetime use
  • 10. Regular use (> 2x /month) of psychoactive drugs other than nicotine, alcohol or caffeine
  • 11. Contraindications to MRI
  • 12. Known contraindication to psychedelic drugs
  • 13. Current participation in other psychedelics or alcohol studies
  • 14. Prior participation in similar studies within the UCL Clinical Psychopharmacology Unit
  • 15. Previous familiarity with movies used in MRI scanning

研究者

发起方
niversity College London

相似试验